These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2447735)

  • 21. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia.
    Giles FJ; Cortes JE; Thomas DA; Garcia-Manero G; Faderl S; Jeha S; De Jager RL; Kantarjian HM
    Clin Cancer Res; 2002 Jul; 8(7):2134-41. PubMed ID: 12114413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.
    Keung YK; Beaty M; Powell BL; Molnar I; Buss D; Pettenati M
    Leuk Res; 2004 Jun; 28(6):579-86. PubMed ID: 15120934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Yasukawa M; Fujiwara H; Ochi T; Suemori K; Narumi H; Azuma T; Kuzushima K
    Am J Hematol; 2009 May; 84(5):314-5. PubMed ID: 19338044
    [No Abstract]   [Full Text] [Related]  

  • 25. [The MIC classification].
    Woessner S; Solé F
    Sangre (Barc); 1990 Feb; 35(1):1-3. PubMed ID: 2333578
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on CFU-mix of 47 patients with leukemia and myelodysplastic syndrome.
    Chen Y; Wang BM; Li CY; Yu DJ
    Chin Med J (Engl); 1989 Jun; 102(6):425-30. PubMed ID: 2512062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aleukemic leukemia cutis preceding overt acute myeloid leukemia in myelodysplastic syndrome.
    Rodríguez JN; Fernandez-Jurado A; Navarro A; Martino ML; Prados D
    Am J Hematol; 1997 Jan; 54(1):91-2. PubMed ID: 8980276
    [No Abstract]   [Full Text] [Related]  

  • 31. Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls.
    Farhi DC
    Pathol Annu; 1995; 30 ( Pt 1)():29-57. PubMed ID: 7731744
    [No Abstract]   [Full Text] [Related]  

  • 32. Polymorphism analysis of CYP3A5 in myeloid leukemia.
    Liu TC; Lin SF; Chen TP; Chang JG
    Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon (a virus inhibiting factor)--approach to prevention and treatment].
    Kishida T
    Nihon Rinsho; 1971; 29(4):1212-7. PubMed ID: 4931319
    [No Abstract]   [Full Text] [Related]  

  • 34. [Leukemias in advanced age. Part 2: Myelodysplastic syndrome and chronic leukemia].
    Jehn U
    Fortschr Med; 1994 May; 112(13):180-4. PubMed ID: 8020858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological characterization of normal and leukemia-associated antigens of acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Mohanakumar T; Miller DS; Anderson J; Metzgar RS
    Cancer Res; 1978 Mar; 38(3):716-22. PubMed ID: 75058
    [No Abstract]   [Full Text] [Related]  

  • 37. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
    Phekoo KJ; Richards MA; Møller H; Schey SA;
    Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
    Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich EJ; Andersson BS; O'Brien S; Andreeff M; Fisher H; Cork A
    N Engl J Med; 1993 Sep; 329(11):757-61. PubMed ID: 7688862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of blast crisis of chronic myelogenous leukemia with lymphoid blasts possessing B-cell markers (author's transl)].
    Ohno R; Ueda R; Suzuki H; Tanaka M; Ezaki K; Kawashima K; Yamada K; Yoshikawa H; Shamoto M; Kawabe M
    Rinsho Ketsueki; 1978 Feb; 19(2):166-71. PubMed ID: 306451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.